https://imedsciences.com/ editor_ijims@hotmail.com
ISSN: 2394-4137 (E) 2394-6318 (P)

IJIMS.2019.105

Type of Article: Original Research

Volume 6; Issue 3: 2019

Page No.: 797-801

DOI: 10.16965/ijims.2019.105

RELATIONSHIP OF BLOOD PRESSURE WITH QTC INTERVAL AND C-REACTIVE PROTEIN

Karthik M 1, Mahantha M *2.

1 Assistant Professor, Department of Physiology, Nimra Institute of Medical Sciences, Vijayawada, Andhra Pradesh, India.

*2 Assistant Professor, Department of Physiology, The Oxford Medical College, Hospital & Research Centre, Yadavanahalli, Bangalore, Karnataka, India.

Corresponding author: Dr. Mahantha. M, Assistant Professor, Department of Physiology, The Oxford Medical College, Hospital & Research Centre, Yadavanahalli, Bangalore, Karnataka, India.

E-Mail: mkmy46@gmail.com

ABSTRACT:

Background: C-reactive protein (CRP) is a systemic inflammatory marker used extensively. QTc interval represents both ventricular depolarization and repolarization. Hypertension is one of the foremost leading causes of morbidity and mortality globally.

Objectives: To explore the relationship of systolic blood pressure with QTc interval and CRP levels. Likewise to investigate the association of diastolic blood pressure with QTc interval and CRP levels.

Materials and Methods: The study was carried out on 100 randomly selected subjects in the age group of 20-45 years. Both genders were included. Hypertensive subjects on treatment were also included. Three records of blood pressure in the supine position were obtained with 2 minute interval between each and average was considered. QT interval and RR interval were measured from standard 12 lead electrocardiogram (ECG). Tangent method was used for QT interval and later it was corrected for heart rate to arrive at QTc interval using Bazett’s formula. CRP levels were obtained using high sensitivity (hs-CRP) assay kits.

Results: There was a positive and significant association for systolic blood pressure with both QTc and CRP. Likewise we also found a positive and significant association for diastolic blood pressure with both QTc and CRP.

Discussion: The inflammatory modulatory processes are altered in hypertension, thereby increasing CRP levels. CRP increases endothelin-1 and reduces nitric oxide leading to vasoconstriction and hypertension. Further CRP causes autonomic imbalances by increasing sympathetic activity that lead to hypertension and indirectly prolonging QTc interval. QTc interval is also lengthened by left ventricular hypertrophy as a complication of hypertension.

Conclusion: Hypertension with left ventricular hypertrophy can cause cardiac arrhythmias and sudden cardiac death. This may be prevented by early detection of high risk hypertensive subjects or even those prone to develop hypertension using QTc and CRP indicators. Further these markers are cheap and widely used and they provide valuable diagnostic and prognostic features especially in developing countries like India.

Key words: systolic blood pressure, diastolic blood pressure, QTc interval, CRP levels, high sensitivity-CRP, hs-CRP, hypertension.

REFERENCES

  1. Solanki JD, Gadhavi BP, Makwana AH, Mehta HB, Shah CJ, Gokhale PA. QTc interval in young Gujarati hypertensives: Effect of disease, antihypertensive monotherapy, and coexisting risk factors. J Pharmacol Pharmacother 2016;7:165-70.
  2. Solanki JD, Gadhavi BP, Makwana AH, Mehta HB, Shah CJ, Gokhale PA. Early screening of hypertension and cardiac dysautonomia in each hypertensive is needed inference from a study of qtc interval in Gujarat, India. Int J Prev Med 2018;9:62.
  3. Peng et al. Heart rate–corrected QT interval duration is significantly associated with blood pressure in Chinese hypertensives. Journal of Electrocardiology. 2006; 39:206–210.
  4. Christian Ukena, Felix Mahfoud, Ingrid Kindermann, Reinhard Kandolf, Michael Kindermann, and Michael Bo¨hm. Prognostic electrocardiographic parameters in patients with suspected myocarditis European Journal of Heart Failure. 2011; 13:398–405.
  5. Medenwald D, Kors JA, Loppnow H, Thiery J, Kluttig A, et al. Inflammation and Prolonged QT Time: Results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) Study. PLoS ONE. 2014; 9(4):e95994.
  6. George Davey Smith, et al. Association of C-Reactive Protein With Blood Pressure and Hypertension Life Course Confounding and Mendelian Randomization Tests of Causality. Arterioscler Thromb Vasc Biol. May 2005; 1051-1056.
  7. Howard D Sesso, et al. C-Reactive Protein and the Risk of Developing Hypertension. JAMA. December 10, 2003; 290(22):2945-2951. (Reprinted)
  8. Pietro Enea Lazzerini, et al. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. European Journal of Internal Medicine. 2013; 24:368–374.
  9. Aroon D. Hingorani, et al. C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clinical Chemistry. 2009; 55(2):239–255.
  10. Akintunde AA, Oyedeji AT, Familoni OB, Ayodele OE, Opadijo OG. QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria. J Cardiovasc Dis Res. 2012;3:290-5.
  11. Ki Chul Sung, Jung Yul Suh, et al. High Sensitivity C-Reactive Protein as an Independent Risk Factor for Essential Hypertension. American Journal of Hypertension. 2003; 16:429–433.
  12. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoproteincholesterol. Metabolism. 2003; 52:1113-6.
  13. Kim E, Joo S, Kim J, Ahn J, Kim J, Kimm K, et al. Association between C-reactive protein and QTc interval in middle-aged men and women. Eur J Epidemiol. 2006; 21:653-9.
  14. Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A, Lowe G, Smith GD, Wilkinson IB, Ben-Shlomo Y: Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009, 53(2):150–157.
  15. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A, Gallacher J, Ben-Shlomo Y, Cockcroft JR, Wilkinson IB: An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension. 2010; 56(1):36–43.
  16. Noseworthy PA, Peloso GM, Hwang SJ, Larson MG, Levy D, O’Donnell CJ, et al. QT interval and long‑term mortality risk in the Framingham Heart Study. Ann Noninvasive Electrocardio. 2012; 17:340‑
  17. Isezuo SA. Systemic hypertension in blacks: an overview of current concepts of pathogenesis and management. Niger Postgrad Med J. 2003; 10:144-53.
  18. Mozos I, Serban C. The relation between QT interval and Twave variables in hypertensive patients. J Pharm Bioallied Sci. 2011; 3:339-44.
  19. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002; 106:913-919.
  20. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I, Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002; 106: 1439-1441.
  21. Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002; 105:1890-1896.
  22. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003; 107: 398-404.
  23. Wang CH, LI SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003; 107: 1783-1790.
  24. Srikumar N, Brown NJ, Hopkins PN, et al. PAI-1 in human hypertension: relation to hypertensive groups. Am J Hypertens. 2002; 15: 683-690.
  25. Garcia-Ortiz L, Ramos-Delgado E, Recio-Rodriguez JI, Agudo-Conde C, Martinez-Salgado C, Patino-Alonso MC, Rodriguez-Sanchez E, Gomez-Marcos MA, Group FV: Peripheral and central arterial pressure and its relationship to vascular target organ damage in carotid artery, retina and arterial stiffness. Development and validation of a tool. The Vaso risk study. BMC Publ Health. 2011; 11(1):266.
  26. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 1999; 84:1018-1022.
  27. Dana E. King, et al. Fiber and C-Reactive Protein in Diabetes, Hypertension, and Obesity. Diabetes Care. 2005 June; 28(6):1487-1489.
  28. Kai-Ting Chang, et al. Association between C-reactive protein, corrected QT interval and presence of QT prolongation in hypertensive patients.Kaohsiung Journal of Medical Sciences. 2014; 30:310-315.

Download Full Text TOC